Leukotrienes: Underappreciated mediators of innate immune responses

Journal of Immunology

Volumn 174, Issue 2, 2005, Pages 589-594

  Peters Golden, Marc ^a,c   Canetti, Claudio ^a   Mancuso, Peter ^b   Coffey, Michael J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Division of Pulmonary and Critical Care Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LEPTIN; LEUKOTRIENE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHODIESTERASE INHIBITOR; THEOPHYLLINE;

ANTIMICROBIAL ACTIVITY; ASTHMA; BRONCHOSPASM; DRUG TARGETING; FATTY ACID SYNTHESIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; LEUKOCYTE; MALNUTRITION; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 12144267623     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.2.589     Document Type: Short Survey

References (103)

1. Lewis, R. A., K. F. Austen, and R. J. Soberman. 1990. Leukotrienes and other products of the 5-lipoxygenase pathway: biochemistry and relation to pathobiology in human disease. N. Engl. J. Med. 323:645.
2. Funk, C. 2001. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294:1871.
3. Kanaoka, Y., and J. A. Boyce. 2004. Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses. J. Immunol. 173:1503.
4. 2. Prostaglandins Leukot. Essent. Fatty Acids 69:87.
5. Peters-Golden, M., and T. G. Brock. 2003. 5-lipoxygenase and FLAP. Prostaglandins Leukot. Essent. Fatty Acids 69:99.
6. 4 receptors. Prostaglandins Leukot. Essent. Fatty Acids 69:123.
7. Hopkins, H., T. Stull, S. Von Essen, R. Robbins, and S. Rennard. 1989. Neutrophil chemotactic factors in bacterial pneumonia. Chest 95:1021.
8. Volovitz, B., R. Welliver, G. De Castro, D. Krystofik, and P. Ogra. 1988. The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease. Pediatr. Res. 24:504.
9. Qadri, F., R. Raqib, F. Ahmed, T. Rahman, C. Wenneras, S. K. Das, N. H. Alam, M. M. Mathan, and A. M. Svennerholm. 2002. Increased levels of inflammatory mediators in children and adults infected with Vibrio cholerae O1 and O139. Clin. Diagn. Lab. Immunol. 9:221.
10. 4 concentrations in children with Helicobacter pylori colonization. Turk J. Pediatr. 41:335.
11. 4 levels during viral upper respiratory tract infections. Ann. Allergy Asthma Immunol. 91:270.
12. Mancuso, P., T. Standiford, T. Marshall, and M. Peters-Golden. 1998. 5-Lipoxygenase reaction products modulate rat alveolar macrophage phagocytosis of Klebsiella pneumoniae. Infect. Immun. 66:5140.
13. Claesson, H., J. Lindgren, and B. Gustafsson. 1985. Opsonized bacteria stimulate leukotriene synthesis in human leukocytes. Biochim. Biophys. Acta 836:361.
14. Coffey, M. J., S. M. Phare, and M. Peters-Golden. 2004. Role of leukotrienes in killing of Mycobacterium bovis by neutrophils. Prostaglandins Leukot. Essent. Fatty Acids. 71:185.
15. Locksley, R., J. Fankhauser, and W. Henderson. 1985. Alteration of leukotriene release by macrophages ingesting Toxoplasma gondii. Proc. Natl. Acad. Sci. USA 82:6922.
16. Castro, M., T. I. Morgenthaler, O. A. Hoffman, J. E. Standing, M. S. Rohrbach, and A. H. Limper. 1993. Pneumocystis carinii induces the release of arachidonic acid and its metabolites from alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 9:73.
17. Wolf, J. E., S. E. Massof, and S. P. Peters. 1992. Alterations in murine macrophage arachidonic acid metabolism following ingestion of nonviable Histoplasma capsulatum. Infect. Immun. 60:2559.
18. Hennet, T., H. J. Ziltener, K. Frei, and E. Peterhans. 1992. A kinetic study of immune mediators in the lungs of mice infected with influenza A virus. J. Immunol. 149:932.
19. Gosselin, J., and P. Borgeat. 1997. Epstein-Barr virus modulates 5-lipoxygenase product synthesis in human peripheral blood mononuclear cells. Blood 89:2122.
20. Malaviya, R., and S. N. Abraham. 2000. Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis. J. Leukocyte Biol. 67:841.
21. 4) from human eosinophils following adherence to IgE- and IgG-coated schistosomula of Schistosoma mansoni. Immunology 69:435.
22. Greenberg, S., and S. Grinstein. 2002. Phagocytosis and innate immunity. Curr. Opin. Immunol. 14:136.
23. Fernandez, N., M. Renedo, S. Alonso, and M. S. Crespo. 2003. Release of arachidonic acid by stimulation of opsonic receptors in human monocyres: the FcγR and the complement receptor 3 pathways. J. Biol. Chem. 278:52179.
24. 4 in human polymorphonuclear leukocytes. Biochem. Biophys. Res. Commun. 99:1230.
25. Rouzer, C., W. Scott, A. Hamill, and Z. Cohn. 1982. Synthesis of leukotriene C and other arachidonic acid metabolites by mouse pulmonary macrophages. J. Exp. Med. 155:720.
26. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4:499.
27. Kimura, K., M. Shiota, K. Mochizuki, M. Ohta, and T. Sugano. 1992. Different preparations of zymosan induce glycogenolysis independently in the perfused rat liver: involvement of mannose receptors, peptide-leukotrienes and prostaglandins. Biochem. J. 283:773.
28. McCurdy, J. D., T. J. Olynych, L. H. Maher, and J. S. Marshall. 2003. Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J. Immunol. 170:1625.
29. Aderem, A., D. Cohen, S. Wright, and Z. Cohn. 1986. Bacterial lipopolysaccharides prime macrophages for enhanced release of arachidonic acid metabolites. J. Exp. Med. 164:165.
30. Coffey, M., S. Phare, and M. Peters-Golden. 2000. Prolonged exposure to lipopolysaccharide inhibits macrophage 5-lipoxygenase metabolism via induction of nitric oxide synthesis. J. Immunol. 165:3592.
31. Brock, T. G., R. W. McNish, P. Mancuso, M. J. Coffey, and M. Peters-Golden. 2003. Prolonged lipopolysaccharide inhibits leukotriene synthesis in peritoneal macrophages: mediation by nitric oxide and prostaglandins. Prostaglandins Other Lipid Mediat. 71:131.
32. Gilchrist, M., S. D. McCauley, and A. D. Befus. 2004. Expression, localization, and regulation of NOS in human mast cell lines: effects on leukotriene production. Blood 104:462.
33. 4. Int. J. Immunopharmacol. 11:801.
34. Bailie, M., T. Standiford, L. Laichalk, M. Coffey, R. Strieter, and M. Peters-Golden. 1996. Leukotriene-deficient mice manifest enhanced lethality from Klebsiella pneumoniae in association with decreased alveolar macrophage phagocytic and bactericidal activities. J. Immunol. 157:5221.
35. Medeiros, A. I., A. Sa-Nunes, E. G. Soares, C. M. Peres, C. L. Silva, and L. H. Faccioli. 2004. Blockade of endogenous leukotrienes exacerbates pulmonary histoplasmosis. Infect. Immun. 72:1637.
36. Chen, N., A. Restivo, and C. S. Reiss. 2001. Leukotrienes play protective roles early during experimental VSV encephalitis. J. Neuroimmunol. 120:94.
37. 4, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 286:264.
38. 4 receptor BLT1 mediates early effector T cell recruitment. Nat. Immunol. 4:982.
39. Parameswaran, K., H. Liang, A. Fariat, R. Watson, D. P. Snider, and M. O. b. P. 2004. Role for cysteinyl leukotrienes in allergen-induced change in circulating dendritic cell number in asthma. J. Allergy Clin. Immunol. 114:73.
40. 4 transporter MRP1 regulates CCL19 (MIP-3β, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 103:757.
41. Maekawa, A., K. F. Austen, and Y. Kanaoka. 2002. Targeted gene disruption reveals the role of cysteinyl leukotriene 1 receptor in the enhanced vascular permeability of mice undergoing acute inflammatory responses. J. Biol. Chem. 277:20820.
42. 4 synthesis in vivo and attenuation of the acute inflammatory response. Mol. Cell. Biol. 21:5389.
43. Hebert, M.-J., T. Takano, H. Holthofer, and H. Brady. 1996. Sequential morphologic events during apoptosis of human neutrophils: modulation by lipoxygenase-derived eicosanoids. J. Immunol. 157:3105.
44. Lee, E., T. Robertson, J. Smith, and S. Kilfeather. 2000. Leukotriene receptor antagonists and synthesis inhibitors reverse survival in eosinophils of asthmatic individuals. Am. J. Respir. Crit. Care Med. 161:1881.
45. 4 on macrophage association with and intracellular destruction of Trypanosoma cruzi. J. Immunol. 134:1989.
46. 4 on macrophage association with and intracellular fate of Trypanosoma cruzi. Mol. Biochem. Parasitol. 15:1.
47. 4 augments neutrophil phagocytosis of Klebsiella pneumoniae. Infect. Immun. 69:2011.
48. 4-regulated event involved in macrophage phagocytosis of IgG-coated targets but not apoptotic cells. Blood 102:1877.
49. Coffey, M., S. Phare, S. George, M. Peters-Golden, and P. Kazanjian. 1998. Granulocyte colony-stimulating factor administration to HIV-infected subjects augments reduced leukotriene synthesis and anticryptococcal activity in neutrophils. J. Clin. Invest. 102:663.
50. Yong, E. C., E. Y. Chi, and W. R. Henderson, Jr. 1994. Toxoplasma gondii alters eicosanoid release by human mononuclear phagocytes: role of leukotrienes in interferon γ-induced antitoxoplasma activity. J. Exp. Med. 180:1637.
51. 4 induces nitric oxide synthesis in Trypanosoma cruzi-infected murine macrophages and mediates resistance to infection. Infect. Immun. 70:4247.
52. 4 is a complete secretagogue in human neutrophils: a kinetic analysis. Biochem. Biophys. Res. Commun. 107:1006.
53. 4 to humans. J. Infect. Dis. 189:2001.
54. 4. FEBS Lett. 244:357.
55. 4 in human polymorphonuclear leukocytes. Blood 93:1399.
56. Hubbard, N., and K. Erickson. 1995. Role of 5-lipoxygenase metabolites in the activation of peritoneal macrophages for tumoricidal function. Mol. Immunol. 160:115.
57. 4. Biochem. Biophys. Res. Commun. 128:297.
58. 4 induces lung generation of tumor necrosis factor-α that in turn mediates neutrophil diapedesis. Surgery 113:297.
59. 4 strongly increases monocyte chemoattractant protein-1 in human monocytes. Arterioscler. Thromb. Vasc. Biol. 24:1783.
60. 4. J. Immunol. 167:2869.
61. Mellor, E. A., K. F. Austen, and J. A. Boyce. 2002. Cysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin 4-regulated pathway that is inhibited by leukotriene receptor antagonists. J. Exp. Med. 195:583.
62. Helgadottir, A., A. Manolescu, G. Thorleifsson, S. Gretarsdottir, H. Jonsdottir, U. Thorsteinsdottir, N. J. Samani, G. Gudmundsson, S. F. Grant, G. Thorgeirsson, et al. 2004. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat. Genet. 36:233.
63. Weisbart, R. H., J. C. Gasson, and D. W. Golde. 1989. Colony-stimulating factors and host defense. Ann, Intern. Med. 110:297.
64. Paine, R. III, S. B. Morris, H. Jin, S. E. Wilcoxen, S. M. Phare, B. B. Moore, M. J. Coffey, and G. B. Toews. 2001. Impaired functional activity of alveolar macrophages from GM-CSF-deficient mice. Am. J. Physiol. 281:L1210.
65. Brock, T. G., R. W. McNish, M. J. Coffey, T. C. Ojo, S. M. Phare, and M. Peters-Golden. 1996. Effect of granulocyte-macrophage colony-stimulating factor on eicosanoid production by mononuclear phagocytes. J. Immunol. 156:2522.
66. Pouliot, M., P. McDonald, P. Botgeat, and S. McColl. 1994. Granulocyte/macrophage colony-stimulating factor stimulates the expression of the 5-lipoxygenase-activating protein (FLAP) in human neutrophils. J. Exp. Med. 179:1225.
67. Coffey, M., S. Phare, S. Cinti, M. Peters-Golden, and P. Kazanjian. 1999. Granulocyte-macrophage colony-stimulating factor upregulates reduced 5-lipoxygenase metabolism in peripheral blood monocyres and neutrophils in AIDS. Blood 94:3897.
68. Thomassen, M. J., L. T. Buhrow, M. J. Connors, F. T. Kaneko, S. C. Erzurum, and M. S. Kavuru. 1997. Nitric oxide inhibits inflammatory cyrokine production by human alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 17:279.
69. Benjamim, C. F., S. H. Ferreira, and F. Q. Cunha. 2000. Role of nitric oxide in the failure of neutrophil migration in sepsis. J. Infect. Dis. 182:214.
70. 4 release from rat alveolar macrophages. Eur. J. Pharmacol. 326:53.
71. Coffey, M. J., S. M. Phare, and M. Peters-Golden. 2004. Induction of iNOS by LPS/interferon γ and sepsis downregulates 5-lipoxygenase metabolism in murine alveolar macrophages. Exp. Lung Res. 30:615.
72. Niederman, M., and A. Fein. 1990. Sepsis syndrome, the adult respiratory distress syndrome, and nosocomial pneumonia: a common clinical sequence. Clin. Chest Med. 11:633.
73. La Cava, A., and G. Matarese. 2004. The weight of leptin in immunity. Nat. Rev. Immunol. 4:371.
74. Mancuso, P., A. Gottschalk, S. M. Phare, M. Peters-Golden, N. W. Lukacs, and G. B. Huffnagle. 2002. Leptin-deficient mice exhibit impaired host defense in Gram-negative pneumonia. J. Immunol. 168:4018.
75. 2γ) protein expression. Am. J. Physiol. 287:L497.
76. Calvo, M. S., and S. J. Whiting. 2003. Prevalence of vitamin D insufficiency in Canada and the United States: importance to health status and efficacy of current food fortification and dietary supplement use. Nutr. Rev. 61:107.
77. Balter, M., G. Toews, and M. Peters-Golden. 1989. Multiple defects in arachidonate metabolism in alveolar macrophages from young asymptomatic smokers. J. Lab. Clin. Med. 114:662.
78. 4 associated with AIDS. AIDS 3:651.
79. Coffey, M., S. Phare, P. Kazanjian, and M. Peters-Golden. 1996. 5-Lipoxygenase metabolism in alveolar macrophages from subjects infected with the human immunodeficiency virus. J. Immunol. 157:393.
80. Coffey, M., S. Phare, M. Peters-Golden, and G. Huffnagle. 1999. Regulation of 5-lipoxygenase metabolism in mononuclear phagocytes by CD4 T lymphocytes. Exp. Lung Res. 25:617.
81. Limper, A., K. Offord, T. Smith, and W. I. Martin. 1989. Pneumocystis carinii pneumonia: differences in lung parasite number and inflammation in patients with and without AIDS. Am. Rev. Respir. Dis. 140:1204.
82. 4 in bronchoalveolar lavage fluid from HIV-infected patients with bacterial pneumonia. Respir. Med. 91:317.
83. 4 in cerebrospinal fluid of AIDS patients with cryptococcal meningitis. J. Clin. Lab. Immunol. 47:41.
84. Skerrerr, S., W. Henderson, and T. Martin. 1990. Alveolar macrophage function in rats with severe protein calorie malnutrition: arachidonic acid metabolism, cytokine release, and antimicrobial activity. J. Immunol. 144:1052.
85. 4 generation in granulocytes from protein-energy malnourished chronically ill elderly. J. Intern. Med 247:715.
86. Fried, S. K., M. R. Ricci, C. D. Russell, and B. Laferrere. 2000. Regulation of leptin production in humans. J. Nutr. 130:3127S.
87. Muhe, L., S. Lulseged, K. E. Mason, and E. A. Simoes. 1997. Case-control study of the role of nutritional rickets in the risk of developing pneumonia in Ethiopian children. Lancet 349:1801.
88. 3-deficient rats. Prostaglandins 48:313.
89. 3 upregulates 5-lipoxygenase metabolism and 5-lipoxygenase activating protein in peripheral blood monocytes as they differentiate into mature macrophages. J. Lipid Mediators 6:43.
90. Luo, M., S. M. Jones, S. M. Phare, M. J. Coffey, M. Peters-Golden, and T. G. Brock. 2004. Protein kinase A inhibits leukotriene synthesis by phosphorylation of 5-lipoxygenase on serine 523. J. Biol. Chem. 279:41512.
91. 4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects. Br. J. Pharmacol. 118:1727.
92. 4 inhibitor rolipram. Br. J. Pharmacol. 140:855.
93. 2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP. J. Immunol. 173:559.
94. Campanile, F., A. Giampietri, U. Grohmann, L. Binaglia, M. C. Fiotetti, and P. Puccerti. 1993. Accelerated hematopoietic recovery and protective effect of the cyclooxygenase inhibitor indomethacin in bacterial infection of neutropenic mice. Cell. Immunol. 147:341.
95. 4 synthesis in human neutrophils in vitro. Prostaglandins Leukot. Essent. Fatty Acids 58:105.
96. Kuritzkes, D. R. 2000. Neutropenia, neutrophil dysfunction, and bacterial infection in patients with human immunodeficiency virus disease: the role of granulocyte colony-stimulating factor. Clin. Infect. Dis. 30:256.
97. 4 in normal and in asthmatic subjects. Am. J. Respir. Crit. Care Med. 155:1789.
98. 4 in the human lung: recruitment of neutrophils into the alveolar spaces without a change in protein permeability. J. Clin. Invest. 89:1009.
99. 4 synthesis by polymorphonuclear leukocytes from male patients with diabetes mellitus. Prostaglandins Leukot. Med. 14:305.
100. 4 synthesis in smokers' alveolar macrophages in vitro. J. Clin. Invest. 77:54.
101. Claria, J., E. Titos, W. Jimenez, J. Ros, P. Gines, V. Atroyo, F. Rivera, and J. Rodes. 1998. Altered biosynthesis of leukotrienes and lipoxins and host defense disorders in patients with cirrhosis and ascites. Gastroenterology 115:147.
102. Lu, M.-C., M. Peters-Golden, D. Hostetler, N. Robinson, and F. Derksen. 1996 Age-related enhancement of 5-lipoxygenase metabolic capacity in cattle alveolar macrophages. Am. J. Physiol. 271:L547.
103. Chakraborti, T., M. Mandal, S. Das, and S. Chakraborti. 1999. Age-dependent change in arachidonic acid metabolic capacity in rat alveolar macrophages. Biochem. Mol. Biol. Int. 47:501.